We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+1.19%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$17.7B
AUM Growth
+$1.44B
(+8.9%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
8.95%
Top 10 Holdings %
Top 10 Hldgs %
19.92%
Holding
1,403
New
439
Increased
358
Reduced
346
Closed
241
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$403M |
| 2 |
Walt Disney
DIS
|
+$157M |
| 3 |
CELG
Celgene Corp
CELG
|
+$141M |
| 4 |
Citigroup
C
|
+$137M |
| 5 |
Starbucks
SBUX
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$244M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$178M |
| 3 |
Canadian National Railway
CNI
|
+$146M |
| 4 |
AT&T
T
|
+$139M |
| 5 |
Micron Technology
MU
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.79% |
| 3 | Healthcare | 17.78% |
| 4 | Consumer Staples | 7.98% |
| 5 | Consumer Discretionary | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAVM
426
DELISTED
Cavium, Inc.
CAVM
| $5.03M | 0.03% |
73,149
+58,331
| +394% | +$4.09M |
|
|
NXGN
427
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $5.03M | 0.03% |
303,552
+146,500
| +93% | +$2.36M |
|
428
MaxLinear
MXL
$6.82B
| $4.97M | 0.03% |
410,526
+98,161
| +31% | +$986K |
|
429
Northwest Bancshares
NWBI
$2.28B
| $4.96M | 0.03% |
387,026
+11,908
| +3% | +$147K |
|
430
O'Reilly Automotive
ORLY
$76.6B
| $4.95M | 0.03% |
328,500
+305,910
| +1,354% | +$4.54M |
|
|
AD
431
Array Digital Infrastructure
AD
$3.07B
| $4.94M | 0.03% |
131,189
+33,973
| +35% | +$1.3M |
|
432
Manulife Financial
MFC
$73.5B
| $4.93M | 0.03% |
+265,300
| New | +$4.93M |
|
|
MHFI
433
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $4.91M | 0.03% |
+48,900
| New | +$5.11M |
|
434
Radware
RDWR
$1.19B
| $4.91M | 0.03% |
+221,135
| New | +$5.14M |
|
435
Boston Scientific
BSX
$71.4B
| $4.91M | 0.03% |
277,201
-1,375,826
| -83% | -$24.6M |
|
|
CSH
436
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
| $4.87M | 0.03% |
186,095
-9,601
| -5% | -$255K |
|
|
CEMP
437
DELISTED
Cempra, Inc.
CEMP
| $4.86M | 0.03% |
+141,463
| New | +$5M |
|
|
DYAX
438
DELISTED
DYAX CORPORATION
DYAX
| $4.84M | 0.03% |
+182,804
| New | +$4.85M |
|
439
CarMax
KMX
$8.34B
| $4.78M | 0.03% |
+72,200
| New | +$5.15M |
|
440
International Bancshares
IBOC
$4.59B
| $4.76M | 0.03% |
177,163
+77,033
| +77% | +$2.05M |
|
441
LG Display
LPL
$3.33B
| $4.75M | 0.03% |
409,574
-428,583
| -51% | -$5.78M |
|
442
Mettler-Toledo International
MTD
$28.6B
| $4.75M | 0.03% |
+13,900
| New | +$4.58M |
|
443
Casey's General Stores
CASY
$31B
| $4.72M | 0.03% |
49,300
+10,800
| +28% | +$962K |
|
444
Fortinet
FTNT
$117B
| $4.72M | 0.03% |
+571,000
| New | +$4.43M |
|
445
Navient
NAVI
$858M
| $4.72M | 0.03% |
+259,200
| New | +$5.07M |
|
446
HSBC
HSBC
$356B
| $4.63M | 0.03% |
+115,942
| New | +$4.83M |
|
447
J&J Snack Foods
JJSF
$1.71B
| $4.62M | 0.03% |
41,746
-4,393
| -10% | -$475K |
|
|
BBBY
448
Bed Bath & Beyond
BBBY
$445M
| $4.6M | 0.03% |
271,642
+66,728
| +33% | +$1.13M |
|
|
IRS
449
IRSA Inversiones y Representaciones
IRS
$1.26B
| $4.58M | 0.03% |
264,794
+22,842
| +9% | +$410K |
|
450
Euronet Worldwide
EEFT
$2.7B
| $4.57M | 0.03% |
74,129
+62,600
| +543% | +$3.72M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Arrowstreet Capital held 1,403 positions worth $17.7B, up 8.9% from $16.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Arrowstreet Capital deployed $1.58B of net new capital in Q2 2015, opening 439 new positions and adding to 358 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Union Pacific, an estimated $244M trimmed.
- Arrowstreet Capital's largest Q2 2015 buy was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
- Arrowstreet Capital added most to Apple in Q2 2015, an estimated $403M increase.
- Arrowstreet Capital's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $244M.
- Arrowstreet Capital fully exited Canadian National Railway in Q2 2015, selling an estimated $146M.
- Arrowstreet Capital's ten largest holdings make up 20% of its $17.7B portfolio in Q2 2015.
- Arrowstreet Capital opened 439 new positions and closed 241 in Q2 2015.
- Arrowstreet Capital's portfolio value rose 8.9% quarter-over-quarter to $17.7B.
Based on Arrowstreet Capital's 13F filing for Q2 2015, filed 13 Aug 2015.